Responses
Short report
Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case–control study
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 30 August 2011
- Published on: 30 August 2011Coffee, hepatitis B and hepatocellular carcinoma: study exclusions and omissions are significantShow More
Sir,
As a coffee-drinking virologist, I read Leung et al's report on coffee consumption and risk of hepatocellular carcinoma (HCC) with interest[1].
The authors excluded those "under medication for liver diseases". It is a reasonable assumption that this means that patients who were receiving antiviral therapy for hepatitis B virus (HBV), e.g. lamivudine, entecavir etc. were excluded. Because patients...
Conflict of Interest:
None declared.